Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | FK9893 | SYR / UN |
Patient reports labile hypertension after COVID vaccination. Currently, he is not taking any medications. He is managed through lifestyle and monitoring at this time.
hyperlipidemia, nocturia
labile HTN
none
NKDA
Work up for labile HTN conducted on 2/10/2025 to include and EKG with CBC, CMP, Mg, lipid panel, TSH, renin/aldosterone ratio, metanephrines/catecholamines, and chromogranin A, which were all unremarkable.